Eli Lilly's Global Obesity Drug Expansion: A New Era?
Update: 2025-09-17
Description
Eli Lilly dominates the obesity drug market internationally with its consumer-first strategy, mirroring its US success by partnering with telehealth services to provide easier access to medications. As the company expands across Europe, Asia, and the Middle East, it faces challenges in navigating diverse healthcare systems and ensuring affordability, but aims to revolutionize global obesity management by blending technology with healthcare.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
